FDA-approved vs compounded, plus safety basics FDA-approved branded GLP-1 medications are Wegovy and Ozempic (semaglutide), Zepbound and Mounjaro (tirzepatide), Saxenda and Victoza (liraglutide), and Rybelsus (oral semaglutide tablets)
Initial concerns were raised after findings from the cardiovascular outcome trial (CVOT), Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes 6 (SUSTAIN 6), revealed a greater risk of DR-related complications, defined as the need for laser therapy, intravitreal injections, development of vitreous hemorrhage, and blindness, in semaglutide users compared to placebo (3.0% vs 1.8%, HR=1.76, P =.02)
Ama, hcresel antioksidan kapasiteyi artrmak ve vcudun doal savunma mekanizmalarn desteklemektir
Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohns disease
(2014) 15(11):e493503